Biogen Received European Commission Approval for SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s Ataxia
Source:
Nasdaq GlobeNewswire
/
12 Feb 2024 15:06:00 America/Chicago
N/A
Share on,